EU Pharmaceutical Strategy

Summary: EU Pharmaceutical Activity: Challenges Arising From The Pharmaceutical Strategy And Beyond

EUHealthGov started 2023 with its seventh quarterly seminar on 25th January – a roundtable on EU pharmaceutical activity which encompassed challenges from the much-awaited revisions to the EU pharmaceutical strategy and beyond. We were delighted to be joined by a range of experts to consider different aspects, notably solidarity and vulnerability in access to pharmaceuticals;

Summary: EU Pharmaceutical Activity: Challenges Arising From The Pharmaceutical Strategy And Beyond Read More »

Watch again: EU Pharmaceutical Activity: Challenges Arising From The Pharmaceutical Strategy And Beyond

In case you missed it: On 25th January, EUHealthGov started its 2023 activities with a webinar devoted to EU pharmaceutical activity hosted by Dr Mary Guy (LJMU). We were delighted to host Dr Éloïse Gennet (Aix-Marseille) and Dr Aurélie Mahalatchimy (Aix-Marseille), Professor Wolf Sauter (VU Amsterdam), and Dr Katrina Perehudoff (University of Amsterdam) in a

Watch again: EU Pharmaceutical Activity: Challenges Arising From The Pharmaceutical Strategy And Beyond Read More »